Justin Anslow is a partner in Goodwin's Technology group and Capital Markets practice. He advises high-growth and public companies, investment banks and venture, private equity and institutional investors on complex and market-shaping capital markets and strategic transactions, with a focus on IPOs and follow-on offerings, de-SPAC transactions and PIPE financings. His experience includes high-profile IPOs, large secondary offerings, cross-border transactions and sponsor-backed business combinations. Justin has experience across the full lifecycle of SPAC transactions — from sponsor formation and IPO through business combination and related PIPE financings — and regularly represents target companies, SPAC sponsors, target stockholders and lead PIPE investors in such transactions. He also advises on convertible and high-yield debt offerings and public company M&A. In addition to transactional matters, Justin counsels public companies on SEC reporting, disclosure strategy and stock exchange compliance. Justin’s clients operate primarily in the technology and life sciences sectors, including venture-backed and sponsor-backed companies navigating the public markets.
REPRESENTATIVE MATTERS
- Represented Toast in its $1 billion IPO
- Represented Sam Altman and affiliated entities in connection with the IPO of Reddit
- Represented Dynatrace in connection with a $500 million secondary sale by selling stockholders
- Represented the underwriters in the $100 million follow-on offering by ImmunityBio
- Represented Altimmune in its $75 million registered direct offering
- Represented the underwriters in the $237 million follow-on offering by selling stockholders of KnowBe4
- Acted as US counsel to certain selling stockholders in the IPO of Urban Company on Indian exchanges
Additional IPO experience prior to joining Goodwin includes GAN Limited, BioXcel Therapeutics, Aridis Pharmaceuticals, and multiple SPAC IPOs.
- Representing Freenome in its proposed business combination with Perceptive Capital Solutions Corp.
- Representing Roman DBDR Acquisition Corp. II in its proposed business combination with ThomasLloyd Climate Solutions B.V.
- Representing certain stockholders of Xanadu in connection with the proposed business combinations of Xanadu and Crane Harbor Acquisition Corp.
- Represented BridgeBio Oncology Therapeutics in its business combination with Helix Acquisition Corp. II
- Represented Circle Internet Financial in its proposed business combination with Concord Acquisition Corp.
- Represented Forge Global in its business combination with Motive Capital Corp.
- Represented Frazier Life Sciences Acquisition Corp. in its business combination with NewAmsterdam Pharma
- Represented the existing stockholders of Zapata AI, Wag!, Aurora Innovation, and Vacasa in their respective de-SPAC transactions
- Represented RA Capital as lead investor in the $240 million PIPE of Cidara Therapeutics
- Represented RA Capital as lead investor in the $130 million PIPE of SAB Biotherapeutics
- Represented Vivo Capital as lead investor in PIPE financings of Minerva Neurosciences, Delcath Systems, Gracell BioTechnologies, and Unicycive Therapeutics
- Represented investors in the $540 million PIPE of Tharimmune
- Represented Greenlight BioSciences in its $110 million PIPE transaction
- Represented the initial purchasers in the $460 million convertible senior notes offering by Box
- Represented the initial purchasers in the $300 million convertible senior notes offering by Rapid7
- Represented eMagin in its sale to Samsung
- Represented Ask Sage in its sale to BigBear.ai
- Represented Superhuman in its sale to Grammarly
- Represented Vector Atomic in its sale to IonQ
- Represented Markforged in its sale to Nano Dimension
- Represented Predibase in its sale to Rubrik
Professional Experience
Prior to joining Goodwin, Justin was an associate in the New York office of Sheppard, Mullin, Richter & Hampton LLP.
Credentials
Education
JD
The George Washington University Law School
BBA
University of Wisconsin-Madison
Admissions
Bars
- New York
Recognition & Awards
Justin has been recognized by The Best Lawyers in America as Ones to Watch for 2024 and 2025.